What does CUSIP 23254L603 represent in this 13F holders report?

CUSIP 23254L603 is the security identifier for CYCC - CYCLACEL PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held CYCC - CYCLACEL PHARMACEUTICALS INC - COM in Q1 2021?

32 institutional investors reported CYCC - CYCLACEL PHARMACEUTICALS INC - COM for Q1 2021. Use the holders table for investor-level position and value details.

CYCLACEL PHARMACEUTICALS INC - COM (CYCC)

CUSIP: 23254L603

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / COM
Total 13F shares: 4,108,357
Total 13F value: $29,218,197
Share change: +2,465,961
SEC-reported price per share: $7.11
Number of holders: 32
Value change: +$17,249,164
Number of buys: 25
Number of sells: 7

Security key

23254L603

Report period

Q1 2021

Institutions

Top holders

CYCC full security history Ownership snapshot Full 13F holder table Bio Green Med Solution, Inc. SEC filings Bio Green Med Solution, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CYCC - CYCLACEL PHARMACEUTICALS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

PURA VIDA INVESTMENTS, LLC

Disclosed value leader

PURA VIDA INVESTMENTS, LLC

Comparable rows

0/15

Latest evidence

31 Dec 2020

13F Highest disclosed value: $3,710,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PURA VIDA INVESTMENTS, LLC has the largest disclosed position value at $3.71M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PURA VIDA INVESTMENTS, LLC's linked filing trail.

Disclosed position value Top 5

PURA VIDA INVESTMENTS, LLC $3.71M

Ikarian Capital, LLC $3.06M

Commodore Capital LP $2.07M

ACUTA CAPITAL PARTNERS, LLC $1.17M

Affinity Asset Advisors, LLC $918K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PURA VIDA INVESTMENTS, LLC	13F Company 13F	— denominator unverified	$3,710,000 475,000 shares	—	31 Dec 2020
Ikarian Capital, LLC	13F Company 13F	— denominator unverified	$3,057,000 391,450 shares	—	31 Dec 2020
Commodore Capital LP	13F Company 13F	— denominator unverified	$2,067,000 264,690 shares	—	31 Dec 2020
ACUTA CAPITAL PARTNERS, LLC	13F Company 13F	— denominator unverified	$1,172,000 150,000 shares	—	31 Dec 2020
Affinity Asset Advisors, LLC	13F Company 13F	— denominator unverified	$918,000 117,545 shares	—	31 Dec 2020
MORGAN STANLEY	13F Company 13F	— denominator unverified	$898,000 115,000 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

4,108,357

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q1 2021 value	Value change	Value Chg %